Turid Hellevik

1.7k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Turid Hellevik is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Turid Hellevik has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Turid Hellevik's work include Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Research and Treatments (3 papers). Turid Hellevik is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Research and Treatments (3 papers). Turid Hellevik collaborates with scholars based in Norway, United States and United Kingdom. Turid Hellevik's co-authors include Iñigo Martínez-Zubiaurre, Iñigo Martínez, Norma W. Andrews, Sabyasachi Chakrabarti, Bård Smedsrød, Lill‐Tove Busund, Roy M. Bremnes, Anthony J. Chalmers, Leila Risteli and Jukka Melkko and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Turid Hellevik

26 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation

2014 376 citations Turid Hellevik, Iñigo Martínez-Zubiaurre Frontiers in Oncology profile →

Peers

Turid Hellevik

ONCOL

IMMUN

Shu‐Fen Chiang Taiwan

Laith Dabbagh Canada

Martin Schlesinger Germany

Oscar J. Cordero Spain

Béatrice Cambien France

Lucillia Bezu France

Ethel R. Pereira United States

Yong Wan United States

Monther Al‐Alwan Saudi Arabia

Jun Chung United States

Shu‐Fen Chiang Taiwan

Turid Hellevik

694 ×1.1

ONCOL

725 ×1.4

504 ×1.5

IMMUN

238 ×0.9

88 ×0.4

Citations per year, relative to Turid Hellevik Turid Hellevik (= 1×) peers Shu‐Fen Chiang

Countries citing papers authored by Turid Hellevik

Since Specialization

Citations

This map shows the geographic impact of Turid Hellevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turid Hellevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turid Hellevik more than expected).

Fields of papers citing papers by Turid Hellevik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Turid Hellevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turid Hellevik. The network helps show where Turid Hellevik may publish in the future.

Co-authorship network of co-authors of Turid Hellevik

This figure shows the co-authorship network connecting the top 25 collaborators of Turid Hellevik. A scholar is included among the top collaborators of Turid Hellevik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turid Hellevik. Turid Hellevik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hellevik, Turid, et al.. (2024). Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts. Cancer Reports. 7(3). e2018–e2018. 2 indexed citations

Gundersen, Kristian, et al.. (2024). Immunological signatures from irradiated cancer-associated fibroblasts. Frontiers in Immunology. 15. 1433237–1433237. 7 indexed citations

Martínez-Zubiaurre, Iñigo & Turid Hellevik. (2023). Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?. Cell Communication and Signaling. 21(1). 108–108. 19 indexed citations

Hellevik, Turid, et al.. (2021). Immunobiology of cancer-associated fibroblasts in the context of radiotherapy. Journal of Translational Medicine. 19(1). 437–437. 22 indexed citations

Hellevik, Turid, et al.. (2021). Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells. Frontiers in Immunology. 12. 662594–662594. 30 indexed citations

Yang, Nannan, et al.. (2021). Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells. Frontiers in Immunology. 11. 602530–602530. 35 indexed citations

Rodrı́guez, René, Sofía T. Menéndez, Marı́a Victoria González, et al.. (2020). GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β. Cell Death and Disease. 11(11). 985–985. 16 indexed citations

Kilvær, Thomas K., Mehrdad Rakaee, Turid Hellevik, et al.. (2019). Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC. Scientific Reports. 9(1). 10163–10163. 24 indexed citations

Hellevik, Turid, et al.. (2019). OC-0154 Radiation abrogates fibroblast-mediated immunosuppressive effects on dendritic cells. Radiotherapy and Oncology. 133. S74–S74. 1 indexed citations

10.

Kilvær, Thomas K., Mehrdad Rakaee, Turid Hellevik, et al.. (2018). Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer. PLoS ONE. 13(2). e0192157–e0192157. 43 indexed citations

11.

Martínez-Zubiaurre, Iñigo, Anthony J. Chalmers, & Turid Hellevik. (2018). Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma. Frontiers in Immunology. 9. 1679–1679. 37 indexed citations

12.

Camilio, Ketil André, et al.. (2017). Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts. Scientific Reports. 7(1). 46714–46714. 41 indexed citations

13.

Kilvær, Thomas K., Mehrdad Rakaee, Turid Hellevik, et al.. (2015). Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers. PLoS ONE. 10(8). e0134965–e0134965. 73 indexed citations

14.

Gorchs, Laia, Turid Hellevik, Jack‐Ansgar Bruun, et al.. (2015). Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation. Frontiers in Oncology. 5. 87–87. 58 indexed citations

15.

Hellevik, Turid & Iñigo Martínez-Zubiaurre. (2014). Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation. Frontiers in Oncology. 4. 1–1. 376 indexed citations breakdown →

16.

Hellevik, Turid, Ingvild Pettersen, Vivian Berg, et al.. (2013). Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth. Translational Oncology. 6(1). 66–74. 53 indexed citations

17.

Hellevik, Turid, Ingvild Pettersen, Vivian Berg, et al.. (2012). Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiation Oncology. 7(1). 59–59. 84 indexed citations

18.

Hellevik, Turid, Iñigo Martínez, Randi Olsen, et al.. (1998). Transport of Residual Endocytosed Products Into Terminal Lysosomes Occurs Slowly in Rat Liver Endothelial Cells. Hepatology. 28(5). 1378–1389. 23 indexed citations

19.

Hellevik, Turid, et al.. (1996). Intracellular Fate of Endocytosed Collagen in Rat Liver Endothelial Cells. Experimental Cell Research. 223(1). 39–49. 21 indexed citations

20.

Melkko, Jukka, Turid Hellevik, Leila Risteli, Juha Risteli, & Bård Smedsrød. (1994). Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells.. The Journal of Experimental Medicine. 179(2). 405–412. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact